Logo CICANCER

Old CIC Events

10x Genomics Technical Day 24/02/2026

10x Genomics Technical Day

Various speakers — -

Proteomic approaches for disentangling oncogenic kinase signalling and for advancing personalized therapies 19/02/2026

Proteomic approaches for disentangling oncogenic kinase signalling and for advancing personalized therapies

Pedro Rodríguez Cutillas — Instituto de Parasitología y Biomedicina López-Neyra (CSIC), Granada

Targeted Replacement of the NKG2A Checkpoint with CARs at the KLRC1 Locus Enhances NK Cell Immunotherapy in AML 12/02/2026

Targeted Replacement of the NKG2A Checkpoint with CARs at the KLRC1 Locus Enhances NK Cell Immunotherapy in AML

Asunción Borrego Borrego — Centro de Investigación del Cáncer (Universidad de Salamanca-CSIC)

Plasticity and CXCR4 in colorectal cancer metastasis 05/02/2026

Plasticity and CXCR4 in colorectal cancer metastasis

Jan Paul Medema — Scientific director and head of Oncode Institute, Department Head LEXOR – Amsterdam UMC

Somatic mutation and selection in ageing tissues. 29/01/2026

Somatic mutation and selection in ageing tissues.

Íñigo Martincorena — Sanger Institute (Cambridge, UK)

Gaining mechanistic insights into long-range gene regulation through synthetic biology approaches 22/01/2026

Gaining mechanistic insights into long-range gene regulation through synthetic biology approaches

Álvaro Rada-Iglesias — Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC/University of Cantabria

Using CRISPR to understand DNA break repair 15/01/2026

Using CRISPR to understand DNA break repair

Felipe Cortés — CNIO

Defensa de tesis doctoral: Características genéticas hereditarias y adquiridas en síndromes de activación  mastocitaria y mastocitosis 19/12/2025

Defensa de tesis doctoral: Características genéticas hereditarias y adquiridas en síndromes de activación mastocitaria y mastocitosis

Paula Navarro Navarro — Programa de doctorado de biociencias: biología y clínica de cáncer

The evolving role of SOS1 as a druggable target in RAS-driven cancer therapeutics 18/12/2025

The evolving role of SOS1 as a druggable target in RAS-driven cancer therapeutics

Fernando Calvo Baltanás — University of Seville

Defensa de tesis doctoral: “Non-redundant roles of SOS1 and SOS2 RAS-GEFs in systemic metabolism, hepatocellular carcinoma, and intestinal integrity" 12/12/2025

Defensa de tesis doctoral: “Non-redundant roles of SOS1 and SOS2 RAS-GEFs in systemic metabolism, hepatocellular carcinoma, and intestinal integrity"

Andrea Olarte San Juan — Programa de doctorado de biociencias: biología y clínica de cáncer

CIC-RAICEX  Connecting Science and Talent Worldwide 12/12/2025

CIC-RAICEX Connecting Science and Talent Worldwide

Rodrigo García Valiente and Nagore de León — RAICEX President & President of the Association of Fellows of the Alfonso Martín Escudero Foundation

Highjacked tissue regeneration as a unifying principle of cancer host interaction 11/12/2025

Highjacked tissue regeneration as a unifying principle of cancer host interaction

Ilaria Malanchi — Francis Crick Institute, London (UK)